N

Neuramedy

5 employees

Neuramedy provides research on neurodegenerative disorders focused on alpha-synuclein and related mechanisms for Parkinson's disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Parkinson's
Alpha Synuclein
Synucleinopathy
neurodegeneration
Medical
Market Research
Professional Services
Lewy body
TLR2

Date founded

2019

Funding rounds raised

Total raised

$6.4M

from 5 investors over 5 rounds

N

Neuramedy raised $6.4M on July 21, 2020

Investors: STIC Ventures, Hana Ventures and Industrial Bank of Korea

N

Neuramedy raised undisclosed on July 3, 2019

Investors: TIPS Town and Devsisters Ventures

FAQ